8-K: Diversified Healthcare Trust Announces Third Quarter 2024 Results, Focuses on Strategic Initiatives

Diversified Healthcare Trust (DHC) reported its third quarter 2024 financial results, highlighting progress in SHOP performance and debt reduction, despite a net loss.

Summary

• Diversified Healthcare Trust (DHC) announced its financial results for the quarter ended September 30, 2024, revealing a net loss of $98.7 million, or $0.41 per share.
• Normalized Funds From Operations (FFO) was $4.0 million, or $0.02 per share.
• The company's portfolio includes 368 properties across 36 states and Washington, D.C., valued at approximately $7.2 billion.
• DHC's portfolio consists of 8.2 million square feet of medical office and life science properties and over 27,000 senior living units.
• SHOP occupancy increased by 100 basis points year-over-year to 79.4%, with average monthly rates up by 5.4%, leading to a 6.4% increase in SHOP revenues.
• Consolidated SHOP Net Operating Income (NOI) increased 32.6% year-over-year to $27.4 million.
• DHC has agreements or letters of intent to sell 28 properties for gross proceeds of $348.1 million, with $302.1 million earmarked for debt redemption.
• The company had approximately $261.4 million in cash and cash equivalents and restricted cash as of September 30, 2024.
• A quarterly distribution of $0.01 per share was declared on October 16, 2024, payable on or about November 14, 2024.

Sentiment

Score: 4

Explanation: The document presents mixed results. While there are positive aspects like SHOP revenue growth and strategic asset sales, the significant net loss and declining FFO raise concerns. The overall sentiment is cautiously negative due to the financial losses.

Positives

• SHOP occupancy and average monthly rates showed positive growth.
• SHOP revenues and NOI experienced significant year-over-year increases.
• The company is actively reducing debt leverage through property dispositions.
• DHC secured higher rents on new leases in its Medical Office and Life Science Portfolio.
• DHC has a substantial amount of cash and cash equivalents.

Negatives

• DHC reported a net loss of $98.7 million, or $0.41 per share.
• Normalized FFO was $4.0 million, or $0.02 per share, which is down from previous periods.
• Medical Office and Life Science Portfolio occupancy decreased year-over-year.
• Same Property Cash Basis NOI for the Medical Office and Life Science Portfolio decreased by 0.2% year-over-year.

Risks

• The company faces risks related to unfavorable market conditions, including high interest rates and inflation.
• There are risks associated with the financial strength of DHC's managers and tenants.
• DHC's ability to maintain or increase occupancy and rental rates is subject to market conditions.
• The company's redevelopment and repositioning activities are subject to cost and timing risks.
• DHC's ability to comply with debt covenants and make required payments is a risk.
• There are potential conflicts of interest with related parties.
• The company is exposed to litigation and regulatory proceedings.

Future Outlook

DHC aims to strengthen performance, improve its balance sheet, and reduce debt leverage through strategic initiatives, including property dispositions and active asset management. The company expects to close on the sale of 22 properties in the fourth quarter of 2024 and the first quarter of 2025.

Management Comments

• Christopher Bilotto, President and CEO, stated that DHC continued to make progress on strategic initiatives, including improving SHOP performance and reducing debt leverage.
• He noted that while SHOP NOI was less than forecasted, the company achieved growth in SHOP occupancy and average monthly rate.
• Bilotto highlighted the expansion of the disposition program, with 28 properties under agreements or letters of intent to sell for $348.1 million.

Industry Context

The healthcare REIT sector is facing challenges due to high interest rates, inflation, and labor shortages. DHC's focus on improving SHOP performance and reducing debt aligns with industry trends of optimizing operations and strengthening balance sheets. The company's active disposition program is also a common strategy in the current market to improve liquidity and reduce leverage.

Comparison to Industry Standards

• DHC's SHOP occupancy of 79.4% is below the pre-pandemic industry average of around 85-90% for senior housing, indicating room for improvement.
• The 5.4% increase in average monthly rates in SHOP is a positive sign, but needs to be compared to the rate increases of competitors like Welltower (WELL) and Ventas (VTR) to assess relative performance.
• The 32.6% year-over-year increase in SHOP NOI is significant, but it's important to compare this to the growth rates of peers such as Healthpeak Properties (PEAK) to understand DHC's relative position.
• The net loss of $98.7 million is concerning and needs to be benchmarked against the profitability of other healthcare REITs to determine if this is an outlier or a broader trend.
• The planned property dispositions for $348.1 million are a positive step towards debt reduction, but the execution and pricing need to be compared to similar transactions by competitors to assess their effectiveness.
• DHC's leverage ratios, such as net debt to annualized Adjusted EBITDAre at 10.6x, should be compared to the industry average to determine if the company is over-leveraged.

Stakeholder Impact

• Shareholders will be impacted by the net loss and reduced FFO, but may be encouraged by the strategic initiatives and debt reduction efforts.
• Employees may be affected by the ongoing property dispositions and operational changes.
• Tenants and residents may experience changes due to the company's focus on improving property performance and occupancy.
• Creditors will be impacted by the company's debt reduction efforts and ability to meet financial obligations.

Next Steps

• DHC will hold a conference call on November 5, 2024, to discuss the third quarter 2024 financial results.
• The company expects to close on the sale of 22 properties in the fourth quarter of 2024 and the first quarter of 2025.
• DHC will continue to focus on improving SHOP performance and reducing debt leverage.

Key Dates

Keywords

Healthcare REIT, Senior Living, Medical Office, Life Science, Real Estate Investment Trust, Property Dispositions, Debt Reduction, SHOP, Net Operating Income, Occupancy